These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1696507)
21. Effects of verapamil on the cellular accumulations and toxicity of several antitumor drugs in 9-hydroxy-ellipticine-resistant cells. Delaporte C; Charcosset JY; Jacquemin-Sablon A Biochem Pharmacol; 1988 Feb; 37(4):613-9. PubMed ID: 3342098 [TBL] [Abstract][Full Text] [Related]
22. Effect of human interferon on vesicular stomatitis virus released from bovine embryonic kidney cells. Harrell SA; Maheshwari RK; Mohanty SB; Friedman RM Am J Vet Res; 1982 Apr; 43(4):565-8. PubMed ID: 6176154 [TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase. Mestan J; Brockhaus M; Kirchner H; Jacobsen H J Gen Virol; 1988 Dec; 69 ( Pt 12)():3113-20. PubMed ID: 2462015 [TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta inhibits the antiviral action of interferons in human embryonic fibroblasts. Zielińska-Jenczylik J; Inglot AD; Inglot O; Popik W J Interferon Res; 1991 Apr; 11(2):87-9. PubMed ID: 1714487 [TBL] [Abstract][Full Text] [Related]
25. A bioassay for interferon type I based on inhibition of Sendai virus growth. Perler L; Pfister H; Schweizer M; Peterhans E; Jungi TW J Immunol Methods; 1999 Jan; 222(1-2):189-96. PubMed ID: 10022385 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells. Samuel CE; Knutson GS Virology; 1983 Oct; 130(2):474-84. PubMed ID: 6316641 [TBL] [Abstract][Full Text] [Related]
27. Thyroid hormone potentiates the antiviral action of interferon-gamma in cultured human cells. Lin HY; Thacore HR; Davis PJ; Davis FB J Clin Endocrinol Metab; 1994 Jul; 79(1):62-5. PubMed ID: 8027254 [TBL] [Abstract][Full Text] [Related]
28. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates. Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235 [TBL] [Abstract][Full Text] [Related]
29. Antiviral activity of bovine interferons on primate cells. Tovey MG; Bandu MT; Begon-Lours J; Brouty-Boyé D; Gresser I J Gen Virol; 1977 Aug; 36(2):341-4. PubMed ID: 197203 [TBL] [Abstract][Full Text] [Related]
30. Studies on the mechanism of the interferon-mediated antiviral state to vesicular stomatitis virus in resting mouse peritoneal macrophages. Di Francesco P; Coccia EM; Gessani S; Romeo G; Borghi P; Locardi C; Belardelli F J Gen Virol; 1989 Jul; 70 ( Pt 7)():1899-905. PubMed ID: 2544669 [TBL] [Abstract][Full Text] [Related]
31. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C. Cembrzyńska-Nowak M Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):499-502. PubMed ID: 2484831 [TBL] [Abstract][Full Text] [Related]
32. Effect of cyclic AMP and cyclic GMP on the activity of interferon against herpes simplex virus types 1 and 2, and vesicular stomatitis virus. Stanwick TL; Nahmias AJ Arch Virol; 1982; 72(4):247-56. PubMed ID: 6180707 [TBL] [Abstract][Full Text] [Related]
33. Effect of indomethacin on the antiviral and priming effect of interferon. Rosztóczy I Acta Virol; 1978 May; 22(3):254. PubMed ID: 27979 [No Abstract] [Full Text] [Related]
34. Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels. Weber JM; Stewart RB J Gen Virol; 1975 Sep; 28(3):363-72. PubMed ID: 170377 [TBL] [Abstract][Full Text] [Related]
35. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells. Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103 [TBL] [Abstract][Full Text] [Related]
36. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. Wollmann G; Robek MD; van den Pol AN J Virol; 2007 Feb; 81(3):1479-91. PubMed ID: 17108037 [TBL] [Abstract][Full Text] [Related]
37. [Are immunomodulators capable to improve the activity of nucleoside antiretroviral agents?]. Sinet M; Pocidalo JJ Pathol Biol (Paris); 1993 Oct; 41(8 Pt 2):794-8. PubMed ID: 8309723 [TBL] [Abstract][Full Text] [Related]
38. The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice. De Clercq E; Nuwer MR; Merigan TC J Clin Invest; 1970 Aug; 49(8):1565-77. PubMed ID: 4317283 [TBL] [Abstract][Full Text] [Related]
40. Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus. Kim YS; Sagara J; Kawai A Biol Pharm Bull; 1995 Jun; 18(6):895-9. PubMed ID: 7550128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]